Population pharmacokinetics and dose optimisation of colecalciferol in paediatric patients with chronic kidney disease [PDF]
British Journal of Clinical Pharmacology, 2022 Aims: The prevalence of vitamin D deficiency is high in children with chronic kidney disease (CKD). However, current dosing recommendations are based on limited pharmacokinetic (PK) data.
Arpana Iyengar +2 more
exaly +4 more sources
Importancia relativa de los factores determinantes de los niveles séricos de 25-hidroxi-colecalciferol en la enfermedad renal crónica [PDF]
Nefrologia, 2016 Introducción: El origen de la carencia de vitamina D en la enfermedad renal crónica (ERC) parece multifactorial, pero es incierta la importancia relativa de cada uno de sus potenciales determinantes.
Fernando Caravaca-Fontan +2 more
exaly +5 more sources
Colecalciferol: Uma análise crítica de produtos manipulados e industrializados [PDF]
Infarma: Pharmaceutical Sciences, 2018 Profissionais de saúde tem prescrito cada vez mais vitamina D, visto que sua deficiência representa um problema de saúde coletiva mundial. Adicionalmente, indivíduos têm utilizado esta substância para outros fins além daqueles ligados ao metabolismo ...
10.14450/2318-9312.v30.e4.a2018.pp218-229 +5 more
doaj +2 more sources
Anemia, 2018 Studies had shown that iron-cycling was disturbed by inflammatory process through the role of hepcidin. Pregnancy is characterized by shifts of interleukin.
Raden Tina Dewi Judistiani +15 more
doaj +2 more sources
Efeito da suplementação de colecalciferol nos RNA mensageiros urinários associados ao podócito em pacientes com doença renal crônica [PDF]
Brazilian Journal of Nephrology, 2016 RESUMO Introdução: A vitamina D reduz a albuminúria em pacientes com doença renal crônica (DRC), mas o seu efeito sobre os podócitos glomerulares ainda não é claro.
João Rodolfo Teló Timm +6 more
doaj +3 more sources
Остеопороз и остеопатии, 2014 Alfacalcidol or colecalciferol in combination with ibandronic aciWhen a comparative study of the ibandronic acid (Bonviva) using with two forms of vitamin D (colecalciferol and alfacalcidol) was conducted, it has been showed that in some patients with ...
S S RODIONOVA +2 more
doaj +3 more sources
Mind the gap: Adherence to denosumab dosing and cessation guidelines in Australian residential aged care. [PDF]
Br J Clin PharmacolThis original research used medication administration data to explore adherence to treatment guidelines for the most common osteoporosis medications in long‐term residential aged care (RAC) in Australia. The paper highlights gaps in adherence to treatment guidelines that must be addressed to improve outcomes of older adults living in RAC.
O'Donnell M +7 more
europepmc +2 more sources
Desensitization to colecalciferol in 18 patients with immediate hypersensitivity reactions [PDF]
World Allergy Organization JournalBengu Saylan
exaly +2 more sources
Phosphate, Fractures, and Frustration-A Missed Diagnosis of Oncogenic Osteomalacia Leading to Multisystem Complication. [PDF]
Clin Case RepABSTRACT Persistent hypophosphatemia must prompt thorough evaluation. This case highlights the severe, multisystem consequences of delayed recognition of oncogenic osteomalacia. Early biochemical assessment, imaging, and multidisciplinary involvement are critical to avoid misdiagnosis and prevent irreversible complications such as skeletal fragility ...
Wilson RM, Sturridge L.
europepmc +2 more sources
Utilization and expenditure on medicines for the management of osteoporosis in Ireland: A repeated cross-sectional study. [PDF]
Br J Clin PharmacolAim Osteoporosis is a prevalent skeletal disease characterized by low bone mass and increased fracture risk. Management of osteoporosis typically involves antiresorptive and anabolic therapies, which are reimbursed in Ireland through various drug schemes.
Smith A +4 more
europepmc +2 more sources